» Articles » PMID: 15784469

Human Leukocyte Antigen Class I B and C Loci Contribute to Type 1 Diabetes (T1D) Susceptibility and Age at T1D Onset

Overview
Journal Hum Immunol
Date 2005 Mar 24
PMID 15784469
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Alleles of human leukocyte antigen (HLA) class II genes are well known to affect susceptibility to type 1 diabetes (T1D), but less is known about the contribution of HLA class I alleles to T1D susceptibility. In this study, molecular genotyping was performed at the HLA-B and HLA-C loci for 283 multiplex Caucasian families, previously typed for HLA-A and the class II loci. Allele frequencies were compared between affected siblings and affected family-based controls. Linkage disequilibrium coefficients were calculated for HLA-B-HLA-C haplotypes and for class I-lass II haplotypes. After adjustment for linkage disequilibrium, the following alleles remain associated with T1D: B*1801, B*3906, B*4403, C*0303, C*0802, and C*1601. B and C allele associations were tested for certain T1D-associated DRB1-DQB1 haplotypes, with the following results: B*3801 is protective on DRB1*0401-DQB1*0302 haplotypes, both C*0701 and C*0702 are predisposing on DRB1*0404-DQB1*0302 haplotypes, and B*3906 is predisposing on DRB1*0801-DQB1*0402 haplotypes. As with previous results for HLA-A, HLA-B and HLA-C are associated with age at T1D onset (mean 11.6 +/- 0.3 years). The protective allele B*4403 was associated with older age at onset (15.1 years; p < 0.04), and the predisposing alleles C*0702 and B*3906 were associated with younger age at onset (9.5 years, p < 0.001; and 7.8 years, p < 0.002, respectively). These data support a role for HLA class I alleles in susceptibility to and age at onset of T1D.

Citing Articles

Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions.

Noble J Front Immunol. 2024; 15:1457213.

PMID: 39328411 PMC: 11424550. DOI: 10.3389/fimmu.2024.1457213.


Next-generation sequencing reveals additional HLA class I and class II alleles associated with type 1 diabetes and age at onset.

Robino A, Bevilacqua E, Aldegheri L, Conti A, Bazzo V, Tornese G Front Immunol. 2024; 15:1427349.

PMID: 39185409 PMC: 11341356. DOI: 10.3389/fimmu.2024.1427349.


MethPhaser: methylation-based long-read haplotype phasing of human genomes.

Fu Y, Aganezov S, Mahmoud M, Beaulaurier J, Juul S, Treangen T Nat Commun. 2024; 15(1):5327.

PMID: 38909018 PMC: 11193733. DOI: 10.1038/s41467-024-49588-0.


Human insulin as both antigen and protector in type 1 diabetes.

Amdare N, Shultz L, Greiner D, DiLorenzo T Eur J Immunol. 2024; 54(9):e2350949.

PMID: 38778498 PMC: 11563931. DOI: 10.1002/eji.202350949.


Differences in F pocket impact on HLA I genetic associations with autoimmune diabetes.

Ren X, Amarajeewa A, Jayasinghe M, Garstka M Front Immunol. 2024; 15:1342335.

PMID: 38596688 PMC: 11003304. DOI: 10.3389/fimmu.2024.1342335.


References
1.
Inoue K, Ikegami H, Fujisawa T, Noso S, Nojima K, Babaya N . Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice. Diabetologia. 2004; 47(4):739-47. DOI: 10.1007/s00125-004-1370-2. View

2.
Thomson G, Robinson W, Kuhner M, JOE S, MacDonald M, Gottschall J . Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet. 1988; 43(6):799-816. PMC: 1715606. View

3.
Spielman R, McGinnis R, Ewens W . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993; 52(3):506-16. PMC: 1682161. View

4.
Atkinson M, Maclaren N . The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994; 331(21):1428-36. DOI: 10.1056/NEJM199411243312107. View

5.
Fennessy M, Metcalfe K, Hitman G, Niven M, Biro P, Tuomilehto J . A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia. 1994; 37(9):937-44. DOI: 10.1007/BF00400951. View